Nationwide EVEREST II clinical trial for patients with a serious heart condition known as mitral regurgitation (MR), where blood leaks backward through the mitral valve with each heartbeat.
Ads by Google
A study involving Beaumont Hospital cardiologists shows the WATCHMAN left atrial appendage device to be as good or better than the standard blood thinning treatment in preventing stroke.
Use of tolvaptan for heart failure treatment must be carefully considered, as evidence of long-term benefit is lacking.
Heart failure medication provides some symptom relief, but doesn't reduce the risk of re-hospitalization or death.
On Monday morning, March 19, cardiac surgeons Scott Silvestry opened the chest of a 55-year-old man suffering from chronic heart failure and implanted a Jarvik 2000 Heart Assist System to save his life.
The Texas Heart Institute at St. Luke's Episcopal Hospital is one of five centers selected by the National Institutes of Health to study stem cell treatments for patients with cardiovascular disease.
States are embroiled in a debate over "specialty hospitals" that focus on a single disease process such as heart care or orthopedics.
For cardiac (heart) procedures, Certificate of Need doesn't create the kind of savings and reductions in mortality rates that policymakers thought it would achieve.
Coronary CT angiography is accurate, definitive, much faster and less costly than the standard diagnostic testing for emergency room chest pain patients.
Using the new risk assessment tool, the researchers found that nearly 50 percent of women in the study who were estimated to be at "intermediate risk" for heart attack or stroke based on current guidelines were in fact at significantly higher or lower risk levels.
Physicians have an effective new option for treating atrial fibrillation, a common irregular heart rhythm that can cause stroke.
Monitoring device for patients is changing the way doctors monitor the health of patients with implanted defibrillators.
Adults who met with pharmacists or pharmacy students during a community outreach and screening project about metabolic syndrome, returned four months later with lower risk factors for heart disease.
A large Danish study rebuts the accepted idea that differences in an estrogen gene (ESR1) affect the risk of heart attack and stroke in response to hormone replacement therapy.
Patients whose arteries are clear can go home hours sooner if they came to the hospital with crushing chest pain.
Researchers attempt to determine optimal timing for administration of platelet inhibiting drugs for treatment of patients with acute coronary syndromes.
Among Greek adults, taking regular midday naps is associated with reduced risk of death from heart disease over a six year period.
A document recommending the adoption of stringent quality standards by those who perform percutaneous coronary intervention (PCI) in hospitals not equipped for cardiac surgery.
Trial Involves Injecting Patients' Own (Autologous) Stem Cells into Areas of Their Hearts with Poor Blood Flow.
Chest pain patients are treated differently based on race, gender and insurance.
More than one third died due to potentially heritable genetic defects that impair the heart's rhythm center.
Heart patients in the South Wales Valleys will be diagnosed and treated faster.